Prelude Capital Management’s Strata Critical Medical Inc SRTA Stock Holding History

Prelude Capital Management’s Portfolio SRTA Stock Details SRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.66M	Sell	503,872 -35,638	-7%	-$187K	0.19%	136
2026 Q1	$2.26M	Sell	539,510 -52,869	-9%	-$254K	0.17%	140
2025 Q4	$2.85M	Sell	592,379 -7,842	-1%	-$37.9K	0.21%	104
2025 Q3	$3.04M	Sell	600,221 -291,249	-33%	-$1.29M	0.24%	87
2025 Q2	$3.59M	Buy	+891,470	New	+$2.9M	0.35%	54
2024 Q4	–	Sell	-48,003	Closed	-$141K	–	1236
2024 Q3	$141K	Sell	48,003 -4,307	-8%	-$13.7K	0.01%	1121
2024 Q2	$182K	Buy	52,310 +28,210	+117%	+$94.1K	0.01%	1026
2024 Q1	$68.7K	Buy	+24,100	New	+$74.4K	﹤0.01%	1234

Other funds holding SRTA

Third Point New York $4.68B AUM 37.3% 1-Year Est. Return

NRCM

Northern Right Capital Management Darien, Connecticut $337M AUM 63.03% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

PLC

Pillsbury Lake Capital San Francisco, California $366M AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Prelude Capital Management's SRTA Position: Q2 2026 in Review

Prelude Capital Management reduced its Strata Critical Medical Inc (SRTA) stake by 6.6% in Q2 2026, selling an estimated $187K and leaving 503,872 shares worth $2.66M. The position accounts for 0.19% of the portfolio, ranked #136.

Prelude Capital Management first reported a position in SRTA in Q1 2024 and has held it in 8 quarters since. The position peaked at $3.59M in Q2 2025. 139 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

Prelude Capital Management held 503,872 shares of Strata Critical Medical Inc worth $2.66M as of Q2 2026.
Prelude Capital Management sold 35,638 Strata Critical Medical Inc shares in Q2 2026, an estimated $187K.
Strata Critical Medical Inc made up 0.19% of Prelude Capital Management's portfolio in Q2 2026, its #136 holding.
Prelude Capital Management first reported a position in Strata Critical Medical Inc in Q1 2024 and has held it in 8 quarters since.
Prelude Capital Management's Strata Critical Medical Inc position peaked at $3.59M in Q2 2025.
139 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.